MUKKA PROTEINS LIMITED

Scale -

Revenue is 1449 Rs Cr; Annual Growth is 44 %; 5 Year CAGR is 17 %
Ebitda is 143 Rs Cr; Annual Growth is 30 %; 5 Year CAGR is 28 %
PBT is 28.33 Rs Cr; Annual Growth is 23 %; 5 Year CAGR is 20 %; Continuous Decline over 3 years
PAT is 55.02 Rs Cr; Annual Growth is 17 %; 5 Year CAGR is 22 %

Quarterly Profit is 19.59 Rs Cr; Continuous Decline over 3 Quarters

Profitability -

Quarterly Ebitda Margin is 10 %; Continuous Growth over 3 Quarters
PBDIT Margin is 9.88 %; 5 Year CAGR is 9 %

PAT Margin is 3.79 %; Annual Decline is -19 %; Continuous Decline over 3 years

Return -

ROA is 3.21 %; Annual Decline is -26 %; Continuous Decline over 3 years; 5 Year CAGR is -15 %
ROE is 10.43 %; Continuous Decline over 3 years; 5 Year CAGR is -19 %
Asset Turnover is 107 %; in Bottom Quartile; 5 Year CAGR is -15 %

Efficiency -

Operating cash flow is -111 Rs Cr; Continuous Growth over 3 years; in Bottom Quartile

Quick Ratio is 0.41; Annual Decline is -31 %; Continuous Decline over 3 years; in Bottom Quartile
Current Ratio is 1.23; Continuous Decline over 3 years; in Bottom Quartile
Inventory Turnover Ratio is 2.04; in Bottom Quartile

Solvancy -

Contingent Liabilities is 62.64 Rs Cr; Annual Decline is -50 %; 5 Year CAGR is 71 %

Debt/Equity is 1.54; Annual Growth is 51 %; Continuous Growth over 3 years; in Top Quartile
Long term Debt is 32.1 Rs Cr; Annual Growth is 1174 %; in Top Quartile; 5 Year CAGR is 36 %
Total Debt is 768 Rs Cr; Annual Growth is 71 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 45 %

Quality -

Operating cashflow/ebitda is -78 %; Annual Growth is 24 %; Continuous Growth over 3 years; in Bottom Quartile
Change in Inventories/Total Expenses is -19 %; Continuous Decline over 3 years; in Bottom Quartile

Current Tax/PAT is 34 %; Annual Growth is 45 %; Continuous Growth over 3 years
Operating cashflow/PAT is -202 %; in Bottom Quartile
Exceptional Items/PBT is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector

Major Subsidiaries/Associates

Key Clients

Products

Products

Product details

Operations

Capacity/ Production

Key Facilities

Key Certifications

Raw materials

Search:

Mukka Proteins Upper Circuit Today: Price, Data and Peers

Past/current

Mukka Proteins board approves ?73.58 crore guarantee for Oman subsidiary

Past/current

Mukka Proteins MUKKA: Rs 73.58 Cr Guarantee for Oman Unit

Past/current

Mukka Proteins NSE:MUKKA Reg 74(5) Compliance Q2 FY27

Past/current

Mukka Proteins Ltd receives USDA NOP

Past/current

IFB Agro Industries vs ADF Foods vs Mukka Proteins: Comparison

Past/current

Is Mukka Proteins the Best Stock in Its Sector? A Look at the Numbers

Past/current